Published in Cancer Weekly, January 31st, 2012
"To investigate the role of BRCA1 RING function in tumor suppression and therapy response, we introduced the Brca1(C61G) mutation in a conditional mouse model for BRCA1 -associated breast cancer. In contrast to BRCA1 -deficient mammary carcinomas, tumors carrying the Brca1(C61G) mutation responded poorly to platinum drugs...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2012-01-31)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.